Tilray Brands, Inc. TLRY shares are trading lower Wednesday as the stock pulls back following a recent surge in cannabis stocks.
What To Know: Shares of cannabis stocks have been trending higher recently after the Department of Health and Human Services (HHS) called to move marijuana from Schedule I to Schedule III under the Controlled Substances Act.
In a letter dated August 29, as reported by Bloomberg News, a senior representative from the HHS corresponded with DEA Administrator Anne Milgram to move marijuana to a lower-risk drug category.
However, shares of cannabis stocks pulled back Wednesday from the recent strength, including Tilray.
Related Link: Fincentric by S&P Global: Markit Digital's New Name, But Goal Remains The Same
TLRY Price Action: Shares of TLRY are down 4.38% at $2.95 at the time of publication, according to Benzinga Pro.
Image by Herbal Hemp from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
